Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy
BioPharma Drive: Drug Pricing
MARCH 6, 2025
Elsewhere, Novo started up an online pharmacy and the FDA cleared testing of a base editing therapy for Duchenne. Phase 3 studies for Amgen’s closely watched obesity drug were posted on a federal database.
Let's personalize your content